ATTENDEES FOR 2017

 

Recognising the roles of rare diseases stakeholders, the World Orphan Drug Congress Asia 2017 invites pharmas,
patient groups, government and experts to join the discussion on providing proper medical care
for rare disease patient care in the Asia Pacific region.

 


By Profile
 

Patient Groups

Patient Groups

What can patient groups do to help ease challenges in orphan drug access? Understand industry perspective and collaborate to resolve challenges fast.

DOH/MOH

DOH/MOH

Why not subsidize orphan drugs? Share your perspective; be understood and work toward a solution.

Asian FDAs

Asian FDAs

How can you start to define rare disease? Leverage how others have defined rare disease and provide a pathway for orphan drugs to your rare disease patients.

Pharma, biopharma & biotech

Pharma, biopharma & biotech

Understand Asia’s market access culture and infrastructure. See how best to provide orphan drugs to rare disease patients in the region.

 

 


By Geography
 

46% South East Asia

32% North East Asia

12% USA

5% Europe

5% Australasia


By Job Title
 

  • CEO 

  • Chief Commercial Officer 

  • Chief Medical Officer 

  • VP, Rare Disease Unit 

  • VP, Business Development 

  • VP, Commercial 

  • VP/Director, Market Access/P&R 

  • VP/Director, Regulatory Affairs 

  • VP/Director, Medical Affairs 

  • Patient Advocate/Liaison

 

 

DOWNLOAD PROSPECTUS

 

INTERESTED IN SPONSORING OR EXHIBITING?

Contact Pinky Fadullon at pinky.fadullon@terrapinn.com
or  +65 6322 2738